BioSpace News Archive

Press Releases

Parabilis Medicines to Present Overview of Ongoing Phase 1/2 Study of FOG-001, a β-cateninTCF4 Inhibitor, at Upcoming Medical Meetings

May 30, 2025
·
4 min read
Press Releases

Halia Therapeutics CEO Dr. David Bearss to Deliver Keynote Address at Med Investment Forum 2025 in Abu Dhabi

May 30, 2025
·
2 min read
Press Releases

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

May 30, 2025
·
6 min read
Press Releases

PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla

May 30, 2025
·
5 min read
Press Releases

Adela to Present Data Highlighting Ability of its Tissue-Agnostic Test for MRD Detection and Response Monitoring to Predict Progression and Identify Non-Responders to Immunotherapy in Solid Tumors at the 2025 ASCO Annual Meeting

May 30, 2025
·
4 min read
Press Releases

Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision Medicine to Immunotherapy at RNA Society’s 30th Annual Meeting

May 30, 2025
·
3 min read
Press Releases

Sun Pharma Completes its Acquisition of Checkpoint Therapeutics

May 30, 2025
·
10 min read
Press Releases

Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025

May 30, 2025
·
3 min read
Press Releases

NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association

May 30, 2025
·
13 min read
Press Releases

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors

May 30, 2025
·
5 min read